Molecular Detection and Genetic Characterization of Toxoplasma gondii in Farmed Minks (Neovison vison) in Northern China by PCR-RFLP.

Toxoplasma gondii is a worldwide prevalent parasite, affecting a wide range of mammals and human beings. Little information is available about the distribution of genetic diversity of T. gondii infection in minks (Neovison vison). This study was conducted to estimate the prevalence and genetic characterization of T. gondii isolates from minks in China. A total of 418 minks brain tissue samples were collected from Jilin and Hebei provinces, northern China. Genomic DNA were extracted and assayed for T. gondii infection by semi-nested PCR of B1 gene. The positive DNA samples were typed at 10 genetic markers (SAG1, SAG2 (5'+3' SAG2, alter.SAG2), SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and Apico) using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technology. 36 (8.6%) of 418 DNA samples were overall positive for T. gondii. Among them, 5 samples were genotyped at all loci, and 1 sample was genotyped for 9 loci. In total, five samples belong to ToxoDB PCR-RFLP genotype#9, one belong to ToxoDB genotye#3. To our knowledge, this is the first report of genetic characterization of T. gondii in minks in China. Meanwhile, these results revealed a distribution of T. gondii infection in minks in China. These data provided base-line information for controlling T. gondii infection in minks.

Patogenicidade e virulência de Toxoplasma gondii isolado de suínos de criação artesanal no sul do Brasil / Patogenicity and virulence of Toxoplasmagondii isolated from rustic farm pigs in Southern Brazil

Studies of Toxoplasma gondii infection in pigs are important because they are part of the human food chain. The main routes of transmission of this agent are: carnivorism, fecal-oral and congenital. Six isolates of T. gondii from pigs of rustic farms were evaluated for virulence and pathogenicity. Tachyzoites suspension used in the tests was obtained by aspiration or by washing the peritoneal cavity of mice that had developed ascites. Each sample of living tachyzoites was inoculated into groups of five mice with inoculum of 10¹, 10², 10³, 10(4), 10(5) and 10(6) intraperitoneally. Half of the isolates (3/6) were lethal and caused clinical signs in Swiss albino mice. The minimum lethal dose was 10³ tachyzoites by inoculum. The death of mice that had acute infection occurred between 12 and 26 days post-inoculation. The other three isolates were not pathogenic or virulent for mice. All isolates of the area studied had a high ability to form cysts, what could increase the risk for infection through ingestion of infected animal tissues.

Estudos com Toxoplasma gondii em suínos são relevantes porque seus produtos e subprodutos fazem parte da cadeia alimentar do ser humano. As principais vias de transmissão deste agente são o carnivorismo, fecal-oral e congênita. Seis isolados de Toxoplasma gondii de suínos de criação artesanal foram avaliados quanto à patogenicidade e virulência em camundongos suíços albinos. A suspensão de taquizoítos utilizada nos testes foi obtida através da punção ou lavagem da cavidade peritoneal de camundongos que apresentaram ascite. Cada amostra foi inoculada em grupos de cinco camundongos, com inóculo de 10¹, 10², 10³, 10(4), 10(5) e 10(6) taquizoítos vivos, via intraperitoneal. Dos isolados, 50% (3/6) foram letais e causaram sinais clínicos nos camundongos. A dose mínima letal foi de 10³ taquizoítos. A morte dos animais que apresentaram infecção aguda ocorreu entre 12 e 26 dias após a inoculação. Todos os isolados da região estudada apresentam alta capacidade de formar cistos, o que pode aumentar o risco de infecção pela ingestão de tecidos dos animais infectados pelos mesmos.

Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii.

Prior studies have demonstrated that B cells are important components of protection in vaccinated mice challenged intraperitoneally with a highly virulent type I strain of Toxoplasma gondii parasites. However, it is not known whether B cells are required for vaccinated mice to successfully resist a more physiologically relevant challenge infection with a mildly virulent type II strain of T. gondii. To investigate that question, we vaccinated B cell-deficient C57BL/6 (microMT) mice with an attenuated strain of T. gondii and challenged them with a potentially lethal oral dose of type II T. gondii cysts. Vaccinated microMT mice survived the challenge as well as vaccinated B6 controls, controlled parasites equally well in critical tissues, produced equivalent levels of mRNA for several type 1 cytokines, and exhibited comparably mild histopathology. Thus, a vaccine can protect against infection with a mildly virulent type II strain of T. gondii in the absence of a B cell-dependent immune response.

Impact of prophylactic ganciclovir on bronchoalveolar lavage lymphocyte numbers and phenotypes in murine cytomegalovirus-induced reactivation of Toxoplasma pneumonia.

In a mouse model of cytomegalovirus (CMV)-induced immunosuppression, murine CMV (MCMV) infection results in reactivation of Toxoplasma pneumonia, and prophylactic but not delayed administration of ganciclovir attenuates the severity of this pneumonia. We now report that the protection observed with ganciclovir is associated with blunting of the alterations in bronchoalveolar lavage (BAL) lymphocyte numbers and phenotypes observed in untreated mice. Specifically, prophylactic ganciclovir prevents the usual drop in BAL CD4+ lymphocytes observed in the first week after MCMV injection--that is, the period of MCMV-associated immunosuppression. Furthermore, prophylactic ganciclovir markedly blunts the usual rise in BAL T lymphocytes (CD8+ > CD4+) seen later during the peak of reactivated Toxoplasma pneumonia. These findings suggest that prophylactic ganciclovir can protect animals from virus-associated opportunistic pneumonia by attenuating virus-induced changes in BAL lymphocytes and the attendant suppression of lung immunity.